+32.2%
CVS vs AZN
+55.9%
-23.6%
-56.8%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | AZN | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.7% | +0.3% | -1.0% | -0.7% |
| 7D | -2.2% | -1.6% | -0.6% | -1.9% |
| 30D | -0.1% | +1.1% | -1.1% | -0.3% |
| 3M | -5.2% | -12.1% | +6.9% | -3.3% |
| 6M | +26.9% | -17.1% | +44.0% | +30.7% |
| YTD | +22.1% | -12.0% | +34.0% | +24.1% |
| 1Y | +30.8% | -0.2% | +31.0% | +29.5% |
| 3Y | +54.4% | +26.8% | +27.6% | +44.2% |
| All | +32.2% | +55.9% | -23.6% | +19.7% |
Cumulative growth
Daily Returns
Daily percentage return beside AZN.
Daily Out/Under-Performance
Portfolio return minus AZN return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × AZN return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded AZN wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling